Thrombosis of Subclavian and Internal Jugular Veins Following Severe Ovarian Hyperstimulation Syndrome: A Case Report

Journal of Obstetrics and Gynaecology Canada

Volumn 30, Issue 7, 2008, Pages 590-597

  Alasiri, Saleh A ^a   Case, Allison M ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Internal jugular vein; IVF ET; Severe ovarian hyperstimulation syndrome (OHSS); Subclavian vein; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C; ALBUMIN; ANTINUCLEAR ANTIBODY; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; BUSERELIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; HEMOGLOBIN; HEPARIN; INFUSION FLUID; LUPUS ANTICOAGULANT; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; PROGESTERONE; PROTEIN C; PROTEIN S; PROTHROMBIN; PROTHROMBIN 20210 A; RECOMBINANT FOLLITROPIN; TINZAPARIN; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ADULT; ARM EDEMA; ARTICLE; AZOOSPERMIA; BLOATING; CASE REPORT; CRYSTALLOID; DISEASE SEVERITY; DOPPLER FLOWMETRY; DRUG DOSE REDUCTION; DYSPNEA; ECHOGRAPHY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GONADOTROPIN BLOOD LEVEL; HEMOCONCENTRATION; HOSPITALIZATION; HUMAN; HYPOALBUMINEMIA; HYSTEROGRAPHY; INTERNAL JUGULAR VEIN THROMBOSIS; INTRACYTOPLASMIC SPERM INJECTION; LEUKOCYTOSIS; NAUSEA; NECK PAIN; NULLIGRAVIDA; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; OVARY HYPERTROPHY; PARACENTESIS; PELVIC DISEASE; PELVIC ULTRASOUND; PERIPHERAL EDEMA; PREMATURE LABOR; SONOHYSTEROGRAPHY; TESTICULAR SPERM EXTRACTION; THROMBOPHILIA; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VASECTOMY; VEIN THROMBOSIS; WEIGHT GAIN; JUGULAR VEIN; OVULATION INDUCTION; SUBCLAVIAN VEIN;

ADULT; FEMALE; HUMANS; JUGULAR VEINS; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; SUBCLAVIAN VEIN; VENOUS THROMBOSIS;

EID: 54949128868     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32893-6     Document Type: Article

References (47)

1. Delvigne A., Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 2002, 8:559-577.
2. Whelan J.G., Vlahos N.F. The ovarian hyperstimulation syndrome. Fertil Steril 2000, 73:883-896.
3. Delvigne A., Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update 2003, 9:77-96.
4. Aboulghar M.A., Mansour R.T. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 2003, 9:275-289.
5. Gardner D.K., Weissman A., Howles C.M., Shoham Z. The use of GnRH agonist 2004, 559-608. Textbook of assisted reproductive techniques. Laboratory and clinical perspectives, Taylor and Francis.
6. Kaiser U.B. The pathogenesis of the ovarian hyperstimulation syndrome. N Engl J Med 2003, 349:729-732.
7. Cluroe A.D., Synek B.J. A fatal case of ovarian hyperstimulation syndrome with cerebral infarction. Pathology 1995, 27:344-346.
8. Semba S., Moriya T., Yousef E.M., Sasano H. An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion. Pathol Int 2000, 50:542-549.
9. Delvigne A., Vandromme J., Demeestere I., Leroy F. Unpredictable cases of complicated ovarian hyperstimulation in IVF. Int J Fertil Womens Med 1997, 42:268-270.
10. Ludwig M., Gembruch U., Bauer O., Diedrich K. Ovarian hyperstimulation syndrome (OHSS) in a spontaneous pregnancy with fetal and placental triploidy: information about the general pathophysiology of OHSS. Hum Reprod 1998, 13(8):2082-2087.
11. Al-Shawaf T., Grudzinskas J.G. Prevention and treatment of ovarian hyperstimulation syndrome. Best Pract Res Clin Obstet Gynaecol 2003, 17:249-260.
12. Akerman F.M., Lei Z., Rao C.V., Nakajima S. A case of spontaneous ovarian hyperstimulation syndrome with a potential mutation in the hCG/LH receptor gene. Fertil Steril 2000, 74:403-404.
13. Smits G., Olatunbosun O., Delbaere A., Pierson R., Vassart G., Costagliola S. ovarian hyperstimulation syndrome due to mutation in the follicle-stimulating hormone receptor. N Engl J Med 2003, 349:760-766.
14. Vasseur C., Rodien P., Beau I., Desroches A., Gerard C., de Poncheville L., et al. A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 2003, 349:753-759.
15. Geva E., Jaffe R.B. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 2000, 74:429-438.
16. Levin E.R., Rosen G.F., Cassidenti D.L., Yee B., Meldrum D., Wisot A., et al. Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome. J Clin Invest 1998, 102:1978-1985.
17. Kodama H., Fukuda J., Karube H., Matsui T., Shimizu Y., Tanaka T. Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism. Fertil Steril 1995, 64:1207-1209.
18. Stewart J.A., Hamilton P.J., Murdoch A.P. Thromboembolic disease associated with ovarian stimulation and assisted conception techniques. Hum Reprod 1997, 12:2167-2173.
19. Rao A.K., Chitkara U., Milki A.A. Subclavian vein thrombosis following IVF and ovarian hyperstimulation: a case report. Hum Reprod 2005, 20:3307-3312.
20. Schenker J.G., Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 1978, 30:255-268.
21. Kodama H., Fuknda J., Karube H., Matsui T., Shimizu Y., Tanaka T. Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. Fertil Steril 1996, 66:417-424.
22. Aune B., Hoie K.E., Oian P., Holst N., Osterud B. Does ovarian stimulation for in vitro stimulation induce a hypercoagulable state?. Hum Reprod 1991, 6:925-927.
23. Hignett M., Spence J.E.H., Claman P. Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis. Hum Reprod 1995, 10:121-123.
24. Thill B., Rathat C., Akula A., Blaise M., Pourriat J.L. Thromboembolic accidents in in vitro fertilization. Ann Fr Anesth Reanim 1994, 13:726-729.
25. Aurousseau M.H., Samama M.H., Belhassan A., Herve F., Hugues J.N. Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports. Hum Reprod 1995, 10:94-97.
26. Mills M.S., Eddowes H.A., Fox R., Wardle P.G. subclavian vein thrombosis: a late complication of ovarian hyperstimulation syndrome. Hum Reprod 1992, 7:370-371.
27. Al-Ramahi M., Leader A., Claman P., Spence J. A novel approach to the treatment of ascites associated with ovarian hyperstimulation syndrome. Hum Reprod 1997, 12:2614-2616.
28. Lane D.A., Mannuci P., Bauer K.A., Bertina R.M., Bochkov N.P., Boulyjenkov V., et al. Inherited thrombophilia, Part 1. Thromb Haemost 1996, 76:651-661.
29. Fabregues F., Tassies D., Reverter J.C., Carmona F., Ordinas A., Balasch J. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening. Fertil Steril 2004, 81:989-994.
30. Dulitzky M., Cohen S.B., Inbal A., Seidman D.S., Soriano D., Lidor A., et al. Increased prevelance of thrombophilia among women with severe ovarian hyperstimulation syndrome. Fertil Steril 2002, 77:463-467.
31. Schenker J.G. Prevention and treatment of ovarian hyperstimulation. Hum Reprod 1993, 8:653-659.
32. Tal J., Paz B., Samberg I., Lazaroun N., Scharf M. Ultrasonographic and clinical correlates of metropin versus sequential clomiphene citrate: menotropin for induction of ovulation. Fertil Steril 1985, 44:342-349.
33. Enskog A., Henrisksson M., Unander M., Nilsson L., Brannstrom M. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 1999, 71:808-814.
34. Golan A., Ron-eI R., Herman A., Soffer Y., Weinraub Z., Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 1989, 44:430-440.
35. Orvieto R. Prediction of ovarian hyperstimulation syndrome. Challenging the estradiol mythos. Hum Reprod 2003, 18:665-667.
36. Garicia-Velasco J.A., Isaza V., Quea G., Pellicer A. Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing?. Fertil Steril 2006, 85:547-554.
37. D'Angelo A., Amos N. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews 2002, (3). Art. No.: CD002811. DOI: 10.1002/14651858. CD002811.
38. Levinsohn-Tavor O., Friedler S., Schachter M., Raziel A., Strassburger D., Ron-El R. Coasting-what is the best formula?. Hum Reprod 2003, 18:937-940.
39. European Recombinant LH Study Group Human recombinant lutenizing hormone is as effective as, but safer than, urinary human chorionic gonadotrophin in inducing final maturation and ovulation in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab 2001, 86:2607-2618.
40. Kol S. Luteolysis induced by a gonadotrophin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril 2004, 81:1-5.
41. P.E., Severe OHSS: How many cases are preventable?. Hum Reprod 2000, 15:8-10.
42. Child T.J., Abdul-Jalil A.K., Gulekli B., Tan S.L. In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome. Fertil Steril 2001, 76:936-942.
43. Asch R.H., Ivery G., Goldsman M., Frederick J.L., Stone S.C., Balmaceda J.P. The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Hum Reprod 1993, 8:1015-1020.
44. Shoham Z., Weissman A., Barash A., Borenstein R., Schachter M., Insler V. Intravenous albumin for the prevention of in vitro fertilization program: a prospective, randomized, placebo-controlled study. Fertil Steril 1994, 62:137-142.
45. Isik A.Z., Gokmen O., Zevneloglu H.B., Kara S., Keles G., Gulekli B. intravenous albumin prevents moderate-severe ovarian hyperstimulation in in-vitro fertilization patients: a prospective, randomized and controlled study. Eur J Obstet Gynecol Reprod Biol 1996, 70:179-183.
46. Aboulghar M., Evers J.H., Al-Inany H. Intravenous albumin for preventing severe ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 2002, 2.
47. Budev M.M., Arroliga A.C., Falcone T. Ovarian hyperstimulation syndrome. Crit Care Med 2005, 33(10 suppl):S301-S306.